Endo Global Aesthetics Limited – Trademark Portfolio
Entity Type: 99
Endo Global Aesthetics Limited holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include QWO, ZAEYYA, ZARYSSA, and BUTT FIRST. The owner is based in Ballsbridge, Dublin 4.
First Floor, MINERVA HOUSE
Simmonscourt Road
Ballsbridge, Dublin 4 D04H9P8 , IE
Showing of trademarks Trademarks
Trademark Classifications
Endo Global Aesthetics Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Endo Global Aesthetics Limited have?
Endo Global Aesthetics Limited has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Endo Global Aesthetics Limited file in?
Endo Global Aesthetics Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Endo Global Aesthetics Limited's most well-known trademarks?
Endo Global Aesthetics Limited's registered trademark portfolio includes well-known marks such as QWO, ZAEYYA, ZARYSSA, and BUTT FIRST. These are among 4 currently registered trademarks in the portfolio.
What is Endo Global Aesthetics Limited's trademark registration success rate?
Endo Global Aesthetics Limited has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.